期刊文献+

The optimal atropine concentration for myopia control in Chinese children: a systematic review and network Metaanalysis 被引量:1

下载PDF
导出
摘要 AIM:To figure out whether various atropine dosages may slow the progression of myopia in Chinese kids and teenagers and to determine the optimal atropine concentration for effectively slowing the progression of myopia.METHODS:A systematic search was conducted across the Cochrane Library,PubMed,Web of Science,EMBASE,CNKI,CBM,VIP,and Wanfang database,encompassing literature on slowing progression of myopia with varying atropine concentrations from database inception to January 17,2024.Data extraction and quality assessment were performed,and a network Meta-analysis was executed using Stata version 14.0 Software.Results were visually represented through graphs.RESULTS:Fourteen papers comprising 2475 cases were included;five different concentrations of atropine solution were used.The network Meta-analysis,along with the surface under the cumulative ranking curve(SUCRA),showed that 1%atropine(100%)>0.05%atropine(74.9%)>0.025%atropine(51.6%)>0.02%atropine(47.9%)>0.01%atropine(25.6%)>control in refraction change and 1%atropine(98.7%)>0.05%atropine(70.4%)>0.02%atropine(61.4%)>0.025%atropine(42%)>0.01%atropine(27.4%)>control in axial length(AL)change.CONCLUSION:In Chinese children and teenagers,the five various concentrations of atropine can reduce the progression of myopia.Although the network Meta-analysis showed that 1%atropine is the best one for controlling refraction and AL change,there is a high incidence of adverse effects with the use of 1%atropine.Therefore,we suggest that 0.05%atropine is optimal for Chinese children to slow myopia progression.
出处 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2024年第6期1128-1137,共10页 国际眼科杂志(英文版)
基金 Supported by the National Key R&D Plan“Intergovernmental International Scientific and Technological Innovation Cooperation”(No.2022YFE0132600) Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties(No.SZGSP014) Sanming Project of Medicine in Shenzhen(No.SZSM202311012) Shenzhen Science and Technology Program(No.KCXFZ20211020163814021).
  • 相关文献

参考文献3

二级参考文献2

共引文献4

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部